Let’s start up with the current stock price of Aerpio Pharmaceuticals Inc. (ARPO), which is $1.28 to be very precise. The Stock rose vividly during the last session to $1.355 after opening rate of $1.34 while the lowest price it went was recorded $1.25 before closing at $1.34.
Recently in News on October 26, 2020, Aerpio Announces First Patient Dosed with Razuprotafib in the Phase 2 Trial for the Prevention and Treatment of ARDS in Patients with Moderate-to-Severe COVID-19. The trial in moderate-to-severe patients is Aerpio’s second clinical trial in COVID-19 patients and is funded in part by the U.S. military. You can read further details here
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
Aerpio Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9000 on 08/13/20, with the lowest value was $0.4200 for the same time period, recorded on 03/19/20.
Aerpio Pharmaceuticals Inc. (ARPO) full year performance was 141.51%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Aerpio Pharmaceuticals Inc. shares are logging -32.63% during the 52-week period from high price, and 204.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.42 and $1.90.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3105010 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Aerpio Pharmaceuticals Inc. (ARPO) recorded performance in the market was 105.29%, having the revenues showcasing -4.48% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 53.49M, as it employees total of 12 workers.
Analysts verdict on Aerpio Pharmaceuticals Inc. (ARPO)
During the last month, 0 analysts gave the Aerpio Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3712, with a change in the price was noted +0.1200. In a similar fashion, Aerpio Pharmaceuticals Inc. posted a movement of +10.34% for the period of last 100 days, recording 1,650,487 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARPO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Aerpio Pharmaceuticals Inc. (ARPO): Technical Analysis
Raw Stochastic average of Aerpio Pharmaceuticals Inc. in the period of last 50 days is set at 32.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 12.00%. In the last 20 days, the company’s Stochastic %K was 19.33% and its Stochastic %D was recorded 14.79%.
Let’s take a glance in the erstwhile performances of Aerpio Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 105.29%. Additionally, trading for the stock in the period of the last six months notably improved by 70.28%, alongside a boost of 141.51% for the period of the last 12 months. The shares increased approximately by -5.88% in the 7-day charts and went up by -9.22% in the period of the last 30 days. Common stock shares were lifted by -4.48% during last recorded quarter.